SCHEMBL20684499

SCHEMBL20684499

CCc1ccc(N(C2CCCC2)S(=O)(=O)c2ccc3[nH]ccc3c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 3/20 0.48
▸ RORA P35398 1/20 0.48
▸ BCL2L1 Q07817 1/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ SLC6A2 P23975 5/20 0.42
▸ SLC6A4 P31645 5/20 0.42
▸ SLC6A3 Q01959 5/20 0.42
▸ ESR1 P03372 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CNR1 P21554 2/20 0.39
▸ CNR2 P34972 2/20 0.39
▸ HTT P42858 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR2C P28335 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17858293 0.83 RORC (0.47) RORCRORABCL2L1MCL1SLC6A2
SCHEMBL17858292 0.81 RORC (0.48) RORCRORABCL2L1MCL1SLC6A2
SCHEMBL20684519 0.80 MAPT (0.53) RORCESR1POLBKMT2ACA12
SCHEMBL17843936 0.74 VCAM1 (0.54) RORCRORAHTT
SCHEMBL20684504 0.73 RORC (0.48) RORCRORAESR1POLBCA12
SCHEMBL3653313 0.71 ALDH1A1 (0.53) CA12CA1CA2CA9HTT
SCHEMBL17858322 0.70 RORC (0.51) RORCRORACNR2
SCHEMBL17852206 0.70 RORC (0.53) RORCRORACNR2
SCHEMBL8533738 0.70 CA12 (0.53) CA12CA1CA2CA9
SCHEMBL17852354 0.70 RORC (0.50) RORCPOLBMEN1KMT2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233836-B1 INDAZOLE SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) GALDERMA RES & DEV (FR) 2019-01-30 — — EP disclosed
Send feedback